State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital,
Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China
WANG Siying,ZHENG Xingling,QIN Wenxin. Could Cancer Patients Survive for a Long Time?[J]. Journal of Shanghai Jiao Tong University, 2021, 55(Sup.1): 49-50.
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(1): 7-30.
[2]
MAEMONDO M, INOUE A, KOBAYASHI K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR[J]. The New England Journal of Medicine, 2010, 362(25): 2380-2388.
[3]
SINGH A K, MCGUIRK J P. CAR T cells: Continuation in a revolution of immunotherapy[J]. The Lancet Oncology, 2020, 21(3): e168-e178.
[4]
PAN C, LIU H, ROBINS E, et al. Next-generation immuno-oncology agents: Current momentum shifts in cancer immunotherapy[J]. Journal of Hematology & Oncology, 2020, 13(1): 29.